Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology crawled time : 12:15 save search
APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2022 FINANCIAL RESULTS ON AUGUST 11, 2022
Published: 2022-06-30 (Crawled : 12:15) - apyxmedical.com
FNCTF | News | $11.16 130
|
Communications
|
| O: 1.06%
H: 0.0%
C: 0.0%
APYX | $1.37 8.73% 49K
|
Health Technology
|
| O: -4.17%
H: 0.0%
C: 0.0%
year corporation results
APYX MEDICAL CORPORATION RECEIVES FDA 510(K) CLEARANCE FOR THE USE OF RENUVION TO IMPROVE APPEARANCE OF LAX (LOOSE) SKIN
Published: 2022-07-18 (Crawled : 12:15) - apyxmedical.com
APYX | $1.37 8.73% 49K
|
Health Technology
|
| O: 18.16%
H: 0.0%
C: 0.0%
fda clearance renuvion skin corporation
Ionis' antisense therapies to be featured at the American Heart Association (AHA) Scientific Sessions 2021
Published: 2021-11-12 (Crawled : 12:15) - prnewswire.com
IONS | $42.09 2.48% 330K
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
heart therapy
BioLineRx to Report Third Quarter 2021 Results on November 18, 2021
Published: 2021-11-12 (Crawled : 12:15) - prnewswire.com
BLRX | $0.6368 -5.95% 420K
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
results
Milestone Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical and Corporate Update
Published: 2021-11-12 (Crawled : 12:15) - prnewswire.com
MIST | $1.68 3.07% 68K
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
financial results results milestone
BioCryst to Present at Upcoming Investor Conferences
Published: 2021-11-12 (Crawled : 12:15) - globenewswire.com
BCRX | News | $4.385 -0.57% 3.4M
|
Health Technology
|
| O: -4.22%
H: 0.0%
C: 0.0%
conference presentation
Celyad Oncology Presents Preclinical Data on Allogeneic CAR T Therapy Program and Highlights KEYNOTE-B79 Clinical Trial Design at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published: 2021-11-12 (Crawled : 12:15) - celyad.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
immunotherapy therapy cancer trial car-t preclinical pre-clinical designation
Xencor Presents Updated Data from the Phase 1 Study of Vudalimab, PD-1 x CTLA-4 Bispecific Antibody, at the SITC Annual Meeting
Published: 2021-11-12 (Crawled : 12:15) - biospace.com/
XNCR | $18.585 2.06% 260K
|
Health Technology
|
| O: 0.19%
H: 0.0%
C: 0.0%
phase 1 antibody
Affimed Shares Preclinical Data on Mechanism of Action of two Innate Cell Engagers at the 36th SITC Meeting, Demonstrating their Potential to Induce Antibody Dependent Cellular Phagocytosis and Serial Killing
Published: 2021-11-12 (Crawled : 12:15) - affimed.com
AFMD | $5.22 4.4% 16K
|
Health Technology
|
| O: -0.17%
H: 0.0%
C: 0.0%
potential antibody preclinical pre-clinical
Protagonist Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences
Published: 2021-11-11 (Crawled : 12:15) - prnewswire.com
PTGX S | $27.18 2.14% 150K
|
Health Technology
|
| O: 3.64%
H: 2.6%
C: 1.34%
conference therapeutics
Lyra Therapeutics to Present at Upcoming Virtual Investor Conferences
Published: 2021-11-11 (Crawled : 12:15) - prnewswire.com
LYRA | $5.27 1.15% 92K
|
Health Technology
|
| O: 0.57%
H: 1.28%
C: 0.0%
conference therapeutics
Alkermes Announces First Subject Dosed in Phase 1 Study of ALKS 1140 for the Treatment of Neurodegenerative and Neurological Disorders
Published: 2021-11-11 (Crawled : 12:15) - prnewswire.com
ALKS | $24.35 1.16% 880K
|
Health Technology
|
| O: -1.59%
H: 1.86%
C: -1.05%
treatment neurodegenerative neurological phase 1 phase 2
Synlogic Announces Presentation of Phenylketonuria Data at 14th International Congress of Inborn Errors of Metabolism Meeting
Published: 2021-11-10 (Crawled : 12:15) - prnewswire.com
SYBX | $1.9 3.26% 65K
|
Health Technology
|
| O: 5.0%
H: 2.04%
C: -9.52%
presentation phenylketonuria
2021 Worldwide Pharma, Biotech & Diagnostics Industry Report - Leading Licensing Deals by Value Since 2015
Published: 2021-11-10 (Crawled : 12:15) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -0.54%
H: 0.0%
C: -0.01%
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.66%
H: 0.25%
C: -0.89%
biotech iot diagnostics license diagnostic pharma
Synlogic Reports Third Quarter Financial Results and Provides Business Update
Published: 2021-11-10 (Crawled : 12:15) - prnewswire.com
SYBX | $1.9 3.26% 65K
|
Health Technology
|
| O: 5.0%
H: 2.04%
C: -9.52%
financial results results
Credit Suisse 30th Annual Healthcare Conference – Presentation
Published: 2021-11-10 (Crawled : 12:15) - sutrobio.com
STRO | $3.795 0.66% 500K
|
Health Technology
|
| O: 0.32%
H: 1.26%
C: -0.78%
presentation conference
Anavex Life Sciences Announces Participation at Upcoming Lausanne VIII Workshop Panel - Building Global Momentum for Interventions in Alzheimer’s Disease
Published: 2021-11-10 (Crawled : 12:15) - globenewswire.com
AVXL | $3.705 0.68% 1M
|
Health Technology
|
| O: -7.28%
H: 3.35%
C: -1.43%
disease alzheimer life science anavex alzheimer’s alzheimer's disease alzheimer's
CareDx Acquires MedActionPlan to Directly Support Patients with Better Adherence
Published: 2021-11-10 (Crawled : 12:15) - globenewswire.com
CDNA | $8.43 3.18% 230K
|
Health Technology
|
| O: -1.86%
H: 0.0%
C: 0.0%
Galera Reports Third Quarter 2021 Financial Results and Recent Corporate Updates
Published: 2021-11-10 (Crawled : 12:15) - globenewswire.com
GRTX | $0.1928 1.05% 330K
|
Health Technology
|
| O: -6.49%
H: 5.2%
C: 0.58%
financial results results
PDS Biotech Provides Business Update and Reports Third Quarter 2021 Financial Results
Published: 2021-11-10 (Crawled : 12:15) - globenewswire.com
PDSB | $3.235 8.19% 740K
|
Health Technology
|
| O: -7.24%
H: 2.21%
C: -2.95%
financial results results biotech iot
Gainers vs Losers
| 85% | 15% |
Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M
|
AGBA | $2.99 139.2% 64M
|
Finance
CZOO | $8.67 73.75% 23M
|
EDBL | News | $6.47 72.07% 1.9M
|
MTC | $2.21 41.67% 5.6M
|
Technology Services
OPRT | News | $3.12 38.67% 11M
|
Finance
PALI | $6.59 33.67% 23M
|
Manufacturing
VNRX | $0.7989 33.15% 3.2M
|
Health Technology
BTCM | $3.51 30.0% 730K
|
Arts, Entertainment, and Recrea...
MLEC | $1.81 29.29% 2.8M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.